SEGMENT INFORMATION Profitability (Details)
$ in Millions |
12 Months Ended |
|
Oct. 31, 2017
USD ($)
segment
|
Oct. 31, 2016
USD ($)
|
Oct. 31, 2015
USD ($)
|
| Segment Reporting [Abstract] |
|
|
|
| Number of operating segments | segment |
3
|
|
|
| Percentage of revenue from a single customer |
Less than 10 percent
|
Less than 10 percent
|
Less than 10 percent
|
| Select income statement components (Loss) [Abstract] |
|
|
|
| Total net revenue |
$ 4,472
|
$ 4,202
|
$ 4,038
|
| Income from operations |
841
|
615
|
522
|
| Depreciation expense |
94
|
95
|
98
|
| Share-based compensation |
60
|
58
|
54
|
| Life Sciences and Applied Markets |
|
|
|
| Select income statement components (Loss) [Abstract] |
|
|
|
| Total net revenue |
2,169
|
2,073
|
2,046
|
| Income from operations |
487
|
429
|
380
|
| Depreciation expense |
35
|
36
|
27
|
| Share-based compensation |
30
|
29
|
27
|
| Diagnostics and Genomics |
|
|
|
| Select income statement components (Loss) [Abstract] |
|
|
|
| Total net revenue |
772
|
709
|
662
|
| Income from operations |
149
|
114
|
88
|
| Depreciation expense |
30
|
31
|
37
|
| Share-based compensation |
10
|
10
|
9
|
| Agilent CrossLab |
|
|
|
| Select income statement components (Loss) [Abstract] |
|
|
|
| Total net revenue |
1,531
|
1,420
|
1,330
|
| Income from operations |
338
|
316
|
299
|
| Depreciation expense |
29
|
28
|
34
|
| Share-based compensation |
21
|
21
|
18
|
| Segment Total [Member] |
|
|
|
| Select income statement components (Loss) [Abstract] |
|
|
|
| Total net revenue |
4,472
|
4,202
|
4,038
|
| Income from operations |
974
|
859
|
767
|
| Depreciation expense |
94
|
95
|
98
|
| Share-based compensation |
$ 61
|
$ 60
|
$ 54
|